Reccan granted 3 MSEK from SWElife to support the development of the company´s product for early detection of pancreatic cancer

Reccan AB, together with Lund University and Region Skåne, has been awarded a prestigious grant of 3 MSEK from Swelife/Vinnova. The grant aims to support the company in generating the clinical evidence needed to bring the product closer to market. The project was selected in stark competition, indicating its potential for creating more value in healthcare.

Swelife – For a competitive life science ecosystem in Sweden

Swelife is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners. We support collaboration within academia, industry and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health.